SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 323 filers reported holding SEATTLE GENETICS INC in Q3 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $915,000 | +115.3% | 5,384 | +44.7% | 0.11% | +158.5% |
Q4 2019 | $425,000 | +62.2% | 3,721 | +21.3% | 0.04% | +105.0% |
Q3 2019 | $262,000 | +15.9% | 3,068 | -5.9% | 0.02% | +53.8% |
Q2 2019 | $226,000 | -82.6% | 3,261 | -81.6% | 0.01% | -82.2% |
Q1 2019 | $1,296,000 | -48.7% | 17,694 | -45.9% | 0.07% | -52.9% |
Q3 2018 | $2,524,000 | +341.3% | 32,733 | +199.7% | 0.16% | +400.0% |
Q1 2018 | $572,000 | +181.8% | 10,922 | +192.3% | 0.03% | +210.0% |
Q3 2017 | $203,000 | -54.3% | 3,736 | -59.2% | 0.01% | -75.0% |
Q2 2015 | $444,000 | – | 9,164 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |